Cargando…

FAT1 and PTPN14 Regulate the Malignant Progression and Chemotherapy Resistance of Esophageal Cancer through the Hippo Signaling Pathway

BACKGROUND: Esophageal cancer (EC) is a common malignant tumor, which brings heavy economic burden to patients and society. Therefore, it is important to understand the molecular mechanism of recurrence, metastasis, and drug resistance of esophageal cancer. METHODS: Human esophageal cancer cell line...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yingzhi, Wang, Zhenxin, Zhou, Ling, Ma, Zhaoming, Zhang, Jianguo, Wu, Yan, Shao, Yan, Yang, Yunyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548181/ https://www.ncbi.nlm.nih.gov/pubmed/34712552 http://dx.doi.org/10.1155/2021/9290372

Ejemplares similares

The Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and Beyond
por: Wilson, Kayla E., et al.
Publicado: (2016)

CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathway
por: Xin, Huixian, et al.
Publicado: (2022)

SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling
por: Zhang, Aijia, et al.
Publicado: (2019)

PTPN14 promotes gastric cancer progression by PI3KA/AKT/mTOR pathway
por: Li, Hui, et al.
Publicado: (2023)

Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
por: Ma, Lijuan, et al.
Publicado: (2023)

Zyxin Links Fat Signaling to the Hippo Pathway
por: Rauskolb, Cordelia, et al.
Publicado: (2011)

Methylation and expression of PTPN22 in esophageal squamous cell carcinoma
por: Deng, Jiaying, et al.
Publicado: (2016)

High Expression of PTPN3 Predicts Progression and Unfavorable Prognosis of Glioblastoma
por: Wang, Yu, et al.
Publicado: (2018)

The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity
por: Michaloglou, Chrysiis, et al.
Publicado: (2013)

Progress in the correlation between PTPN12 gene expression and human tumors
por: Huo, Yu-hu, et al.
Publicado: (2020)

Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2
por: Zhou, Xiaofeng, et al.
Publicado: (2020)

PTPN11 hypomethylation is associated with gastric cancer progression
por: Xu, Lele, et al.
Publicado: (2020)

Stathmin levels alter PTPN14 expression and impact neuroblastoma cell migration
por: Po’uha, Sela T., et al.
Publicado: (2019)

Scribble Acts in the Drosophila Fat-Hippo Pathway to Regulate Warts Activity
por: Verghese, Shilpi, et al.
Publicado: (2012)

The palmitoyltransferase Approximated promotes growth via the Hippo pathway by palmitoylation of Fat
por: Matakatsu, Hitoshi, et al.
Publicado: (2017)

RAI14 silencing suppresses progression of esophageal cancer via the STAT3 pathway
por: Wang, Jianlin, et al.
Publicado: (2020)

Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer
por: Mai, Zihang, et al.
Publicado: (2022)

High-Risk Human Papillomavirus E7 Proteins Target PTPN14 for Degradation
por: White, Elizabeth A., et al.
Publicado: (2016)

Verteporfin suppresses osteosarcoma progression by targeting the Hippo signaling pathway
por: Yang, Xianliang, et al.
Publicado: (2021)

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
por: Baumgartner, Christina K., et al.
Publicado: (2023)

Assembly and activation of the Hippo signalome by FAT1 tumor suppressor
por: Martin, Daniel, et al.
Publicado: (2018)

Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
por: Song, Shumei, et al.
Publicado: (2020)

Hippo Pathway in Cancer, towards the Realization of Hippo-Targeted Therapy
por: Hata, Yutaka
Publicado: (2018)

Concomitant deletion of Ptpn6 and Ptpn11 in T cells fails to improve anticancer responses
por: Ventura, Pedro M O, et al.
Publicado: (2022)

Expanded directly binds conserved regions of Fat to restrain growth via the Hippo pathway
por: Fulford, Alexander D., et al.
Publicado: (2023)

Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
por: Sekido, Yoshitaka
Publicado: (2018)

Chaetocin exhibits anticancer effects in esophageal squamous cell carcinoma via activation of Hippo pathway
por: Li, Lin, et al.
Publicado: (2023)

Redoxing PTPN22 activity
por: Shumanska, Magdalena, et al.
Publicado: (2022)

The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression
por: Tu, Chao, et al.
Publicado: (2020)

Curcumin inhibits proliferation of hepatocellular carcinoma cells by blocking PTPN1 and PTPN11 expression
por: Zhang, Jingru, et al.
Publicado: (2023)

The Hippo signaling pathway in gastric cancer: Targeting Hippo for GC treatment
por: Cao, Zhifa, et al.
Publicado: (2023)

Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus
por: Yun, Hye-Yeoung, et al.
Publicado: (2019)

PTPN14 aggravates inflammation through promoting proteasomal degradation of SOCS7 in acute liver failure
por: Fu, Beibei, et al.
Publicado: (2020)

microRNA-217 suppressed epithelial-to-mesenchymal transition through targeting PTPN14 in gastric cancer
por: Chen, Gen, et al.
Publicado: (2020)

RP1-59D14.5 triggers autophagy and represses tumorigenesis and progression of prostate cancer via activation of the Hippo signaling pathway
por: Zhong, Bing, et al.
Publicado: (2022)

Dysregulated YY1/PRMT5 axis promotes the progression and metastasis of laryngeal cancer by targeting Hippo pathway
por: Wang, Nan, et al.
Publicado: (2020)

Esophageal Stricture Resulting from Systemic Chemotherapy for Solid Malignancy
por: Sedhom, Daniel, et al.
Publicado: (2017)

TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
por: Fujii, Makiko, et al.
Publicado: (2012)

Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway
por: Liu, Jie, et al.
Publicado: (2017)

PTPN22.6, a Dominant Negative Isoform of PTPN22 and Potential Biomarker of Rheumatoid Arthritis
por: Chang, Hui-Hsin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f2eal1b9tsbsp76tgjc1d8i0vn